Coronary Atherosclerosis
📧 Sign up to get email alerts when something new happens for Coronary Atherosclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-12-18Clinical Trial Update: AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis [Phase 3]
Phase 3 trial evaluating atorvastatin plus fenofibric acid (TriLipix) for reducing intermediate coronary atherosclerosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-02-24Clinical Trial Update: Endothelial Function-guided Therapy Compared to Usual Care in Patients With NOCAD
A clinical trial evaluating endothelial function-guided therapy versus usual care in patients with non-obstructive coronary artery disease h…